Abivax (ABVX) Change in Cash (2024 - 2026)

Abivax's Change in Cash history runs 3 years deep, the most recent figure standing at -$46.0 million for Q1 2026.

• On a quarterly basis, Change in Cash fell 7.51% year-over-year to -$46.0 million in Q1 2026; TTM through Mar 2026 was $439.0 million, a 396.2% increase from a year earlier, with the FY2025 full-year figure at $433.6 million, up 471.98% from the prior year.
• Change in Cash rose to -$46.0 million in Q1 2026 per ABVX's latest filing, from -$85.0 million in the prior quarter.
• Across five years, Change in Cash topped out at $618.1 million in Q3 2025 and bottomed at -$85.0 million in Q4 2025.
• The 3-year median for Change in Cash is -$42.8 million (2025), against an average of $31.1 million.
• Biggest YoY gain for Change in Cash was 1444.43% in 2025; the steepest drop was 280.84% in 2025.
• Year by year, Change in Cash stood at -$38.7 million in 2024, then sank by 119.56% to -$85.0 million in 2025, then surged by 45.89% to -$46.0 million in 2026.
• Per Business Quant, the three latest ABVX Change in Cash figures stand at -$46.0 million (Q1 2026), -$85.0 million (Q4 2025), and $618.1 million (Q3 2025).